反応式
[Cl:1][C:2]1[C:3]([N:12]2[CH2:18][CH2:17][CH2:16][NH:15][CH2:14][CH2:13]2)=[N:4][CH:5]=[C:6]([C:8]([F:11])([F:10])[F:9])[CH:7]=1.Cl[C:20]1[CH:21]=[CH:22][C:23]2[N:24]([C:26]([C:29]([F:32])([F:31])[F:30])=[N:27][N:28]=2)[N:25]=1>>[Cl:1][C:2]1[C:3]([N:12]2[CH2:18][CH2:17][CH2:16][N:15]([C:20]3[CH:21]=[CH:22][C:23]4[N:24]([C:26]([C:29]([F:30])([F:32])[F:31])=[N:27][N:28]=4)[N:25]=3)[CH2:14][CH2:13]2)=[N:4][CH:5]=[C:6]([C:8]([F:9])([F:10])[F:11])[CH:7]=1参加物
3
実験手順
A mixture of 1-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-1,4-diazepane and 6-chloro-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine was allowed to react by General Synthetic Method 3. The crude product was purified by hplc using a Waters XTerra C18 column (5μ silica, 19 mm diameter, 100 mm length) eluted with decreasingly polar mixtures of water (containing 0.1% aqueous ammonia) and acetonitrile as eluents to give 6-[4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-1,4-diazepan-1-yl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine.
後処理
- customto react by General Synthetic Method 3
- customThe crude product was purified by hplc
- washeluted with decreasingly polar mixtures of water (containing 0.1% aqueous ammonia) and acetonitrile as eluents
出典と根拠
- ORDレコード
- ord-63c28cb328fa44878cdf9f4b0ede4aa2
- 出典データセット
- uspto-grants-2011_08
- 特許番号
- US08003649B2
関連ノート
読み込み中…